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Background: Transcranial magnetic stimulation (TMS) has been frequently used to explore changes in the
human motor cortex in different conditions, while the extent of motor cortex reorganization in patients
in vegetative state (VS) (now known as unresponsive wakefulness syndrome, UWS) and minimally
conscious (MCS) states due to severe brain damage remains largely unknown.
Objective/hypothesis: It was hypothesized that cortical motor excitability would be decreased and would
correlate to the level of consciousness in patients with disorders of consciousness.
Methods: Corticospinal excitability was assessed in 47 patients (24 VS/UWS and 23 MCS) and 14 healthy
controls. The test parameters included maximal peak-to-peak M-wave (Mmax), F-wave persistence,
peripheral and central motor conduction times, sensory (SEP) and motor evoked (MEP) potential
latencies and amplitudes, resting motor threshold (RMT), stimulus/response curves, and short latency
afferent inhibition (SAI). TMS measurements were correlated to the level of consciousness (assessed
using the Coma Recovery Scale-Revised).
Results: On average, the patient group had lower Mmax, lower MEP and SEP amplitudes, higher RMTs,
narrower stimulus/response curves, and reduced SAI compared to the healthy controls (P < 0.05). The SAI
alterations were correlated to the level of consciousness (P < 0.05).
Conclusions: The ﬁndings demonstrated the impairment of the cortical inhibitory circuits in patients with
disorders of consciousness. Moreover, the signiﬁcant relationship was found between cortical inhibition
and clinical consciousness dysfunction.
 2013 Elsevier Inc. All rights reserved.Introduction
Following severe brain damage, disorders of consciousness
(DOC), such as vegetative state (VS) (now known as unresponsive
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ll rights reserved.(MCS) have been linked to poor long term prognosis [2]. The
recovery of consciousness could be related to the number of
surviving neurons and the functional integrity of long-range cor-
tico-cortical and cortico-thalamo-cortical connections [3]. Trans-
cranial magnetic stimulation (TMS) is an objective method to assess
the motor cortex excitability and the integrity of motor pathways
[4]. Several studies indicate that cortical injuries, independent of
their etiology, can lead to a reduced strength of inhibitory neuro-
transmission [5e8]. Paired TMS has been used for over 20 years to
investigate recovery of motor function in stroke patients [9].
Cortical excitability is also shown to correlate with the severity of
brain damage in patients with diffuse traumatic brain injury (TBI)
[10e14] and to be related to the clinical recovery in mild to
moderate TBI [15]. By coupling peripheral nerve stimulation with
TMS, it is possible tomodify the excitability of themotor cortex [16].
This effect, named short-latency afferent inhibition (SAI), is
produced by inhibitory interactions within the cerebral cortex [17].
N. Lapitskaya et al. / Brain Stimulation xxx (2013) 1e82SAI is reduced in cholinergic forms of dementia, while it is normal
in non-cholinergic forms of dementia [18]. The amount of SAI was
found to be decreased in patients with cerebral autosomal domi-
nant arteriopathy with subcortical infarcts and leukoencephalop-
athy and cognitive impairment [19]. Changes in cortical excitability
in patients with DOC due to severe cerebral damage remain largely
unknown [20]. To date, only one study has reported signiﬁcant
differences in motor threshold (MT) levels in persistently unre-
sponsive post-comatose patients with brain injury due to anoxia
and trauma [21]. Therefore, this investigation was designed to
evaluate the cortical motor phenomena that indicate the strength
and integrity of corticospinal pathways in patients with DOC due to
severe brain damage. Moreover, we wanted to assess the relation-
ship between SAI measures in the motor cortex and the clinical
measures of consciousness.
Hypothesis
It was hypothesized that cortical motor excitability would be




Forty seven patients with severe brain damage (trauma, n ¼ 22;
anoxic-ischemic encephalopathy, n ¼ 16; ischemic stroke, n ¼ 2;
hemorrhagic stroke, n ¼ 2; subarachnoidal hemorrhage, n ¼ 4;
encephalitis, n ¼ 1) were prospectively included and met the
criteria [22,23] deﬁning VS/UWS (n ¼ 23; 16 males; mean age  SD
45  22 years; mean time since injury  SD 16  53 months), or
MCS (n ¼ 24; 19 males; mean age  SD 41  17 years; mean time
since injury  SD 36  65 months). MRI was performed within
a week of TMS assessments. See Supplemental Table for individual
MRI descriptions and patient clinical characteristics. All patients
were screened in order to ensure therewere no contraindications to
TMS [24]. No sedative medication was administered prior to the
TMS measurements. Thirteen patients received no centrally acting
drugs, 21 patients received one centrally acting drug (antidepres-
sant (n ¼ 1), anticonvulsant (n ¼ 8), benzodiazepine (n ¼ 2), anti-
spasticity drug (n ¼ 10), and 13 patients received a combination of
two ormore of these drugs. The administration of these drugs could
not be stopped for clinical reasons. Fourteen healthy volunteers
(8 males; mean age  SD 33  11 years) were also tested.
The study was approved by the Ethics Committee of the Liège
University and Liège University Hospital and written informed
consent was obtained from the patient’s legal guardians and
healthy participants.
Clinical assessment
Coma Recovery Scale-Revised (CRS-R) [25] assessment was
performed by an experienced neuropsychologist the day of, day
before and day after the TMS sessions (the highest scorewas chosen
for further analyses). The CRS-R consists of six subscales (auditory,
visual, motor and oromotor/verbal functions, communication and
arousal) and the maximum score is 23. In the current study, mean
total CRS-R score  SD was 4  1 points in VS/UWS patients and
13  5 points in MCS patients. Mean motor CRS-R score  SD was
1  1 points in VS/UWS patients and 3  2 points in MCS patients
(0¼ none/ﬂaccid; 1¼ abnormal posturing; 2¼ ﬂexionwithdrawal;
3 ¼ localization to noxious stimulation; 4 ¼ object manipulation;
5 ¼ automatic motor response; 6 ¼ functional object use).Basic electromyographic recordings (EMG)
EMG was recorded using AgeAgCl surface electrodes over the
ﬁrst dorsal interosseous muscle (FDI). The electrodes were placed
on the metacarpophalangeal joint (reference) and over the motor
point (active). The EMG was recorded with the “Cambridge 1401”
ampliﬁer (Cambridge, U.K.), low pass ﬁltered at 3 kHz and high pass
ﬁltered at 10 Hz. The data were stored on a computer for off-line
analysis. The maximal peak-to-peak M-wave (Mmax) of the FDI
was measured following electrical stimulation of the ulnar nerve
(0.2 ms square-wave constant current pulse) at the wrist with the
cathode placed distally. The supramaximal electrical ulnar nerve
stimulation was performed to elicit a recurrent discharge from
spinal motor neurons (F-wave). F-wave persistence was deﬁned as
the number of potentials with an amplitude of at least 20 mV out of
20 recordings [26]. Peripheral motor conduction time (PMCT) was
measured as the latency of the response from the spinal cord to the
muscle, calculated using the formula (FþM 1)/2, where Fwas the
shortest latency of 20 consecutive F-waves, M was the M-wave
latency, and 1 was the delay time (in ms) for antidromic activation
of the alpha motor neuron [27]. Central motor conduction time
(CMCT) was calculated as the difference between the cortical MEP
latency and PMCT.
Somatosensory evoked potentials (SEPs)
SEPs were registered from both hemispheres as described
previously by Tokimura et al. [17] using the “Cambridge 1401”
ampliﬁer (Cambridge, U.K.). The EEG signal was low pass ﬁltered at
3 kHz and high pass ﬁltered at 10 Hz, and the data were stored on
a computer for off-line analysis. Active skin electrodes were
attached 3 cm posterior to C3 and C4 (10e20 international system)
respectively for the right and left median nerve, and with reference
electrode placed at Fz. A bipolar electrical stimulator was used. Test
parameters were: stimulus duration 0.2 ms; frequency 2 Hz;
intensity: 150% over the motor threshold for abductor pollicis
brevis muscle. Five hundred responses were averaged. The latencies
of the P14 and the N20 peaks were identiﬁed, and the amplitude of
the N20 peak was measured peak-to-peak.
TMS
Both hemispheres were stimulated using TMS (200 stimulator
and ﬁgure of eight shaped coil, Magstim Company Ltd, U.K.), and
test responses in the contralateral FDI were recorded. In all exper-
iments, themagnetic coil was held tangentially to the headwith the
handle pointing backwards and 45 laterally from the midline. The
coil was placed at the cranial site from which a maximum FDI
response was obtained (i.e., the ‘hotspot’). The hotspot was marked
directly on the scalp to ensure constant coil position during the
entire experimental session. The resting threshold intensity (RMT),
expressed as a percentage of the maximum stimulator output
(MSO), was deﬁned as the intensity needed to produce a response
of 50 mV (peak-to-peak) or more in at least ﬁve out of ten consec-
utive stimuli in the relaxed muscle [28]. The RMT was assessed in
both hemispheres. Stimulus/response curves [29] were measured
with a stimulus intensity increasing in 10% steps from RMT to 40%
above RMT. Five trials were performed for each stimulus intensity.
Short latency afferent inhibition (SAI) was measured in the relaxed
muscle by paired-pulse stimulation paradigm [17]. Conditioning
stimuli (CS) were 0.2 ms single pulses of electrical stimulation
applied through bipolar electrodes to the median nerve at the wrist
with the cathode positioned proximally. The intensity of the CS was
slightly greater than motor threshold for abductor pollicis brevis
muscle, and the magnetic test stimulus (TS) had an intensity of
Table 1
Basic clinical and electrophysiological characteristics.
Variables Healthy MCS VS/UWS
Age (years) 33  10 41  17 45  22
Time since injury (months) 36  67 17  54
CRS-R total score (points) 13  5 4  1
CRS-R motor score (points) 3  2 1  1
Mmax (mV) 10  2.3 4.8  2.0a 5.1  2.9a
F-wave persistence (number) 13.5  5.1 16.1  5.8 17.4  4.4
SEP P15peak latency (ms) 14.9  1.2 14.8  1.6 16  2
SEP N20 peak latency (ms) 19.3  1.1 20.5  1.8 20.4  1.6
SEP amplitude (mV) 2.5  1.3 0.93  0.6a 0.9  0.7a
MEP latency (ms) 22.3  1.2 22.5  2.2 22.8  2.4
PMCT (ms) 16.4  1.2 16.7  1.8 16.6  1.6
CMCT (ms) 5.9  1.2 6.2  2.6 6.7  3.3
RMT (% MSO) 39.3  7.6 49.1  18.9 50.9  13.3a
Unconditioned MEP paired-
pulse paradigms (mV)
0.74  0.67 0.88  0.75 0.44  0.59a,b
Bilateral SEPs and MEPs responses were elicited in 16 MCS and 14 VS/UWS patients.
Unilateral SEPs and MEPs responses were elicited in 7 MCS and 5 VS/UWS patients.
In one MCS and two VS/UWS patients no SEPs or MEPs could be elicited from both
hemispheres. In two VS/UWS patients SEPs were present unilaterally and MEPs
responses were absent, while the recording from the other hemisphere was not
performed due to clinical reasons. The presented parameters obtained from the best
hemisphere in patients and from the dominant left hemisphere in healthy controls.
Values are mean  standard deviation.
Abbreviations: MCS ¼ minimally conscious state; VS/UWS ¼ vegetative state/
unresponsive wakefulness syndrome; Mmax ¼ maximum peak-to-peak M-wave;
F-wave persistence¼ number of potentials with an amplitude of at least 20 mV out of
20 F-wave recordings; PMCT ¼ peripheral motor conduction time; CMCT ¼ central
motor conduction time; SEPs ¼ sensory evoked potentials; MEPs ¼ motor evoked
potentials; RMT ¼ resting motor threshold; MSO ¼ maximal stimulator output;
uMEP ¼ unconditioned MEP to the single magnetic test stimulus.
a P< 0.05 between VS/UWS patients and controls, and MCS patients and controls.
b P < 0.05 between VS/UWS patients and MCS.
Figure 1. RMT in patients and healthy controls. RMT values were larger in VS/UWS
(circles) and MCS (triangles) as compared to healthy subjects (squares), P < 0.001. The
decrease of MEP amplitude was observed with increasing RMT. The fed line represents
mean RMT values. Abbreviations: RMT ¼ resting motor threshold; VS/
UWS ¼ vegetative state/unresponsive wakefulness syndrome; MCS ¼ minimally
conscious state; MEP ¼ motor evoked potential.
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were determined relative to the latency of the N20 component of
the SEP: 2, 0, þ2, þ4, þ6, þ8, þ10, þ12, þ14 ms. Each TMS block
consisted of 50 randomized stimuli: ﬁve single TS and ﬁve CS þ TS
at each ISI; the interval between each TS was 8 s.
Statistical analysis
Basic EMG parameters were analyzed with STATA (Stata version
9.2, Texas, U.S.A.). All electrophysiological parameters were
analyzed separately; comparison between the parameters obtained
from different hemispheres was performed by Wilcoxon matched-
pairs signed-ranks tests; parameters of patient group were
compared with those of the controls by means of KruskaleWallis
andManneWhitney tests. Stimulus/response curves and SAI results
were analyzed using a linear mixed model (SAS 9.1 procedure PROC
MIXED; SAS Institute Inc., 2002e2003) with consciousness state
(VS/UWS, MCS, and healthy controls) and stimulation condition (for
the stimulus/response curves: from RMT to RMT þ40% in steps of
10%; for the SAI: single TS and CS þ TS with ISI of 2,
0, þ2, þ4,þ6,þ8,þ10,þ12,þ14 ms relatively to N20) as systematic
factors and subject as a random factor. The random subject factor
also modeled the correlation between repeated measurements on
subjects across stimuli. MEP values were log-transformed, median
MEP values were summarized from ﬁve MEP trials by each stimu-
lation condition per individual. The statistical null hypothesis of no
difference between relative amplitude levels (stimulus/response
curves: relative to RMT response; SAI: relative to the single TS
response) was tested, and if a differencewas detected, the statistical
signiﬁcance of each relative amplitude level was also tested. For the
stimulus/response experiment, the statistical signiﬁcance of the
RMT was tested by adding the natural logarithm of RMT values as
a continuous explanatory variable to the statistical model. Finally,for patients, the association between individual ratios of median
SAI values at N20þ2 ms relative to the median of single TS
responses and the corresponding CRS-R values was tested by the
Spearman correlation coefﬁcient. Results were considered signiﬁ-
cant at P < 0.05.Results
Basic electrophysiological parameters
TMS was tolerated well and no side effects were reported. Both
healthy subjects and patients were instructed to relax during the
entire TMS session. Neither healthy subjects nor patients were
given audioevisual feedback to assist in maintaining complete
relaxation. EMG traces for each trial were visually inspected off-
line, and trials contaminated with voluntary muscle activity were
rejected from the analyses (in the recruitment curves experiment:
31 traces out of 1025 (3%) in patients and 3 out of 350 (0.9%) in
healthy subjects; in the SAI experiment: 79 out of 1900 (4%) in
patients and 2 out of 700 (0.3%) in healthy.
Bilateral SEPs and MEPs responses were elicited in 16 MCS and
14 VS/UWS patients. Unilateral SEPs and MEPs responses were
elicited in 7 MCS and 5 VS/UWS patients. In one MCS and two VS/
UWS patients no SEPs or MEPs could be elicited from both hemi-
spheres. In two VS/UWS patients SEPs were present unilaterally and
MEPs responses were absent, while the recording from the other
hemisphere was not performed due to clinical reasons.
Figure 2. Stimulus/response curves in patients and healthy controls. Individual stimulus/response curves in the FDI recorded in (A) VS/UWS, (B) MCS, and (C) healthy controls. (D)
Model of MEP/Mmax amplitude relative to MEP/Mmax at RMT in the three groups: VS/UWS (black circles); MCS (black triangles); and healthy controls (black squares); empty symbols
represent 95% conﬁdence intervals. Stimulus intensity is expressed as a percentage of the maximum stimulator output and adjusted to RMT. The relative MEP/Mmax curves were
different (P < 0.0001) between VS/UWS patients, MCS patients and healthy controls. Abbreviations: FDI ¼ ﬁrst dorsal interossei muscle; RMT ¼ resting motor threshold; VS/
UWS ¼ vegetative state/unresponsive wakefulness syndrome; MCS ¼ minimally conscious state; MEP ¼ motor evoked potential; Mmax ¼ the maximal peak-to-peak M-wave of the
ﬁrst dorsal interosseous muscle.
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parameters obtained from the best hemisphere in patients and
from the dominant left hemisphere in healthy controls.
TheMmax differed between both VS/UWS and MCS compared to
healthy subjects (P< 0.001), but not between VS/UWS compared to
MCS (P ¼ 0.8). The amplitude of the N20 component of SEPs was
decreased in MCS patients (0.93  0.6 mV, P ¼ 0.03), and VS/UWS
patients (0.9  0.7 mV, P ¼ 0.04) compared to healthy subjects
(2.5  1.3 mV). Unconditioned MEP amplitude was different
between both patient groups compared to healthy subjects
(P < 0.05), and between VS/UWS compared to MCS (P ¼ 0.02). The
RMT differed between VS/UWS compared to healthy subjects
(P¼ 0.01, Fig.1), but not betweenMCS compared to healthy subjects
(P ¼ 0.08) or between VS/UWS compared to MCS (P ¼ 0.5). The
decrease inMEP amplitudewas observedwith increasing RMT (e.g.,
a doubling of RMT reduced MEP amplitude with 70%). MEP
amplitude tended to be higher in patients using centrally acting
drugs (mean 70% (CI [9e216%]), but the effect was not signiﬁcant
(P ¼ 0.09)).
TheMEP and SEP latencies, F-wave persistence, PCMT, and CMCT
did not differ between patient groups and healthy controls
(P > 0.05).
In patients with bilateral SEPs and MEPs responses, basic elec-
trophysiological measures (Mmax, F-wave persistence, PMCT, CMCT,
SEPs latencies and amplitudes, and MEP latencies) were notdifferent between the two recorded sides, while RMT was signiﬁ-
cantly higher in VS/UWS group (57.4  17.7% MSO, range 38e93)
comparing to MCS group (49.4  18.8% MSO, range 28e100) and
healthy controls (34.1  10.4% MSO, range 23e59), (P < 0.05). The
high RMT values introduced many missing values in recruitment
curves and SAI paradigm and were not analyzed further. Patients
with missing SEPs and/or MEPs were excluded from further anal-
yses. The correlation between TMSmeasures and clinical ﬁndings in
patients was analyzed for the measures obtained from the best
hemisphere.
Stimulus/response curves
Stimulus/response curves exhibited a gradual increase in MEP
amplitude with increasing stimulus intensities. Comparisons
revealed differences between the relative MEP curves for VS/UWS,
MCS and healthy controls (P< 0.0001, Fig. 2). Signiﬁcant differences
were shown between VS/UWS and healthy controls (P< 0.005), and
between VS/UWS and MCS (P < 0.005) for 110%, 120%, 130% and
140% of RMT intensities, while no signiﬁcant differences were
found between MCS and healthy controls (P > 0.05). The model
predicted that subject MEP amplitude levels were associated with
RMT values (r ¼ 0.20, P ¼ 0.002) indicating a potential effect of
RMT on MEP values. High values of RMT were more likely to
introduce missing MEP values by exceeding the maximal output
Figure 3. SAI in patients and healthy controls. Individual SAI curves in (A) VS/UWS, (B) MCS, and (C) healthy controls. (D) Model of MEP amplitude relative to unconditioned MEP
response in the three groups: VS/UWS (black circles); MCS (black triangles), and healthy controls (black squares). Nineteen VS/UWS and 19 MCS patients contributed to the SAI data.
The conditioning median nerve stimulation preceded TMS of the contralateral motor cortex (nine different ISI) and was adjusted for the latency of the N20 component of the SEP in
each subject. SAI differed between patient groups and healthy controls (P < 0.0001). The log-transformed ratios of the conditioned/unconditioned MEPs are plotted. Abbreviations:
SAI ¼ short latency afferent inhibition; VS/UWS ¼ vegetative state/unresponsive wakefulness syndrome; MCS ¼ minimally conscious state; MEP ¼ motor evoked potential;
SEP ¼ sensory evoked potential; ISI ¼ interstimuli interval.
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values). This bias was presumably larger for patients.Short afferent inhibition
Relative SAI time courses were different between groups
(P < 0.0001, Fig. 3). The responses were inhibited in healthy
controls with the most pronounced inhibition when the median
nerve stimulus was given at N20 þ 2 ms before the TMS stimulus
(P ¼ 0.0000). At this ISI interval ratios of median SAI values to the
median of single TS responses were 0.31 (CI [0.2e0.48]) in healthy
controls, 0.81 (CI [0.57e1.16]) inMCS, and 0.97 (CI [0.68e1.4]) in VS/
UWS, with a signiﬁcant difference between MCS and healthy
controls (P ¼ 0.0008, CI [1.5e4.54]), and between VS/UWS and
healthy controls (P ¼ 0.00008, CI [1.78e5.44]), while the difference
between VS/UWS and MCS did not reach the signiﬁcance (P ¼ 0.5,
CI [0.72e1.99]). There was no effect of centrally acting medication
(P ¼ 0.7) (inter-individual variation remained 77%). Subgroups
analyses were performed according to the type of brain injury: 1)
anoxia; 2) trauma; 3) non-trauma non-anoxia (including ischemic
and haemorrhagic stroke, subarachnoidal hemorrhage, and
encephalitis). Relative SAI time courses were different betweengroups (P ¼ 0.0395, inter-individual variation 83%, see Fig. 4). As
shown in Fig. 5, the amount of inhibition at N20 þ 2 ms correlated
with CRS-R total scores (r ¼ 0.39, P ¼ 0.02).Discussion
The current study evaluated several excitatory and inhibitory
phenomena in VS/UWS andMCS patients due to severe brain injury
and showed that RMT, stimulus/response curves, and SAI were
signiﬁcantly different between patients with DOC and healthy
controls. In addition, the ﬁndings revealed a relationship between
SAI and clinically assessed levels of consciousness in patients with
severe brain injury.
In the present study no MEPs could be elicited from both
hemispheres in one MCS and four VS/UWS patients. In seven MCS
and ﬁve VS/UWS patients MEPs were only elicited from one
hemisphere. Both VS/UWS and MCS patients presented normal
MEP and SEP latencies, F-wave persistence, PCMT, and CMCT. These
results are in line with Moosavi et al. [21] showing that the absence
of voluntary movements does not invariably predicate an abnormal
motor conduction in post-comatose patients with severe brain
damage. Also studies in stroke patients show that presence or
Figure 4. SAI in patients with different etiology of brain injury. Individual SAI curves in patients with (A) anoxia, (B) trauma, and (C) non-anoxia non-trauma (ischemic and
haemorrhagic stroke, subarachnoidal hemorrhage, and encephalitis). (D) Model of conditioned MEP amplitude relative to unconditioned MEP response in the three groups: anoxia
(black circles); non-anoxia non-trauma (black squares), and trauma (black triangles). Thirty-eight patients contributed to the SAI data. The conditioning median nerve stimulation
preceded TMS of the contralateral motor cortex (nine different ISI) and was adjusted for the latency of the N20 component of the SEP in each subject. SAI differed between patient
groups and healthy controls (P ¼ 0.0395). The log-transformed ratios of the conditioned/unconditioned MEPs are plotted. Abbreviations: SAI ¼ short latency afferent inhibition;
MEP ¼ motor evoked potential; SEP ¼ sensory evoked potential; ISI ¼ interstimuli interval.
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always anticipate clinical improvement of motor function [30,31].
The previous observations made with conventional MEPs showed
that motor deﬁcit can exist in the presence of normal cortico-
motoneuronal conduction times, showing that intactness of these
connections is not a sufﬁcient condition for preservation of
voluntary motor activities [32]. This might indicate the selective
involvement of the small pyramidal tract neurons with a relative
sparing of the large fast conducting corticospinal ﬁbers that are
responsible for MEP [33]. However, both the N20 amplitude,
unconditioned MEP amplitude and the M-wave were decreased
signiﬁcantly in VS/UWS patients. In agreement with previous
reports in critically ill patients [34], presence of a symmetric
sensory and motor axonal neuropathy is common in DOC patients
in the subacute period following brain injury, while myopathic
involvement is rarer and most probably is associated with
neuropathies [35]. For the detection of the failure of corticospinal
tract conduction, the triple stimulation technique, which consists of
one transcranial magnetic and two peripheral electric stimuli
(plexus and nerve) delivered along themotor pathways, might have
higher sensitivity than conventional MEP or CMCT testing [36]. We
observed higher RMTs in VS/UWS patients compared to healthy
controls, while the difference between MCS patients and healthy
subjects was not signiﬁcant. These results conﬁrm previousﬁndings of higher MT in patients recovering from anoxia [21] and
diffuse TBI [14,15]. The RMT is thought to reﬂect membrane excit-
ability in interneuronal circuits within the motor cortex [37].
Diffusion-weighted imaging has also shown that the RMT is
strongly correlated with the structural integrity of the white matter
in the primary motor and premotor cortex [38]. RMT is also
determined by the excitability of spinal motoneurons as discharge
of these are required for an MEP to be evoked in the muscle [39].
However, we found the F-wave persistence to be within normal
limits in both patient groups, suggesting thatmost of the increase in
RMT was caused by reduced cortical excitability. In concurrence
with these ﬁndings, a difference between VS/UWS patients and
healthy controls, and between VS/UWS and MCS patients was
observed in the stimulus/response curves, while no signiﬁcant
differences were found betweenMCS patients and healthy controls.
Compared to RMT, stimulus/response curves assess neurons that
are intrinsically less excitable and further from the centre of acti-
vation of the TMS coil [40], and are believed to reﬂect the size of the
cortical representation and the distribution of excitability within
the corticospinal projections [39].
The present study revealed a signiﬁcantly reduced SAI in
patients with DOC. This is in concurrence with studies demon-
strating a reduced SAI in patients with diffuse TBI [10] and stroke
[41]. Some evidence suggests that SAI is a cortical phenomenon [17]
Figure 5. Correlation of SAI with clinically assessed level of consciousness. The log-
transformed individual ratios of the conditioned/unconditioned MEP amplitudes at
ISI þ 2 ms (relative to N20 component of SEP) were correlated with CRS-R total scores
in VS/UWS and MCS patients (r ¼ 0.39, P ¼ 0.02). Abbreviations: SAI ¼ short latency
afferent inhibition; MEP ¼ motor evoked potential; SEP ¼ sensory evoked potential;
ISI ¼ interstimuli interval; CRS-R ¼ Coma Recovery Scale Revised [25]; VS/
UWS ¼ vegetative state/unresponsive wakefulness syndrome; MCS ¼ minimally
conscious state.
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mechanisms behind SAI abnormalities in DOC remain unclear, but
could possibly involve the withdrawal of tonic facilitation from the
thalamus [44]. Alternatively, subcortical lesions interrupting
ascending cholinergic axons may lead to cortical cholinergic
denervation [45]. However, it cannot be excluded that SAI occurs
via cholinergic modulation of inhibitory circuits rather than direct
inhibitory cholinergic effects [41e43]. The other motor cortex
excitability phenomena (e.g., short intracortical inhibition, ICI;
intracortical facilitation, ICF) are also most likely impaired in
patients with DOC. Reduced ICI and SAI was found in awake
patients with anoxic, traumatic, and non-traumatic diffuse brain
injury [46]. Moreover, the signiﬁcant correlation was found
between the amount of ICI and the severity of brain injury, while no
correlation was found between motor cortex excitability parame-
ters and patient functional level [46]. Both ICI and ICF impairment
was found in ﬁve VS patients [47]. In addition, reduced ICI and ICF
did not change in the two patients who evolved into anMCS [47]. In
this respect, investigation of short and long latency intracortical
inhibition and facilitation in patients with DOCwould be important.
A correlation between SAI and clinically assessed levels of
consciousness was observed, which is in agreement with studies
showing a correlation between SAI and neuropsychological
measures related to long term memory and other cognitive func-
tions in patients with Alzheimer’s disease [48] and vascular
dementia with microbleeds [49,50]. A recent study in acute stroke
patients showed a correlation between SAI and long-term recovery
[41]. The hypothesis that cholinergic neuronal function is impaired
in brain damaged patients is also supported by preliminary phar-
macological studies using acetylcholinesterase inhibitors to
improve memory during acute brain injury rehabilitation [51,52].
Some limitations should be highlighted in the current study.
TMS measurements could be inﬂuenced by the centrally acting
drugs administered to the patients (as standard care in therehabilitation hospital). It has been shown that benzodiazepines
can reduce SAI [53], however, the inﬂuence of other centrally acting
drugs on SAI has not been thoroughly investigated. While some
information has been gathered on how individual drugs inﬂuence
TMS [54], the effects of different drug combinations, often used in
severely brain damaged patients, remain unclear. Despite this, in
the current study, cortical excitabilitymeasures did not reveal drug-
related differences. A second caveat relates to the ﬂuctuating levels
of arousal frequently encountered in DOC patients, possibly altering
the recorded cortical excitability parameters. In the current study,
a standardized arousal facilitation protocol as deﬁned in the CRS-R
[22] was delivered to the patients. While the continuous assess-
ment of arousal in patients with DOC is clinically challenging, future
studies could use simultaneous EEG recordings to assist in identi-
fying sleep patterns during TMS acquisitions. Finally, in the current
study here was heterogeneity in the size, location, severity, and
type of focal lesions in the participants with different brain injury
etiology. Future studies should correlate the amount of inhibition as
measured by TMS with the structural abnormalities in the cholin-
ergic pathways [55] and the integrity of the tissue in subcortical,
thalamic and brainstem regions [56] as measured using MRI (e.g.,
diffusion tensor imaging, fractional anisotropy, voxel-based
morphometry). Nevertheless, this study demonstrates TMS
changes in patients with DOC due to severe brain injury, and
supports TMS as an assessment tool to provide objective comple-
mentary information and add further information to DOC as
cortico-cortical disconnection syndrome [57e59].
In conclusion, the current study is the ﬁrst to provide detailed
information on the integrity of the corticospinal sensorimotor
pathways in patients with DOC due to severe brain damage. The
higher RMTs, narrower stimulus/response curves, and reduced SAI
in patients with DOC might reﬂect a decreased cortical excitability
and a reduced cortical inhibitory activity. Moreover, reduced SAI
correlated with the clinically assessed level of consciousness in
patients with DOC. The hypothesis that reduced SAI is related to
impaired cholinergic neuronal function in patients with DOC
should be explored further in the pharmacological studies. Longi-
tudinal studies in patients with DOC are needed to assess the
relationship between functional recovery of consciousness and
restoration of normal corticospinal and intracortical mechanisms.
This hypothesis, if conﬁrmed, might offer prognostic surrogate
markers and suggest novel therapeutic strategies.
Supplementary data
Supplementary data related to this article can be found, in the
online version, at http://dx.doi.org/10.1016/j.brs.2013.01.002.
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